Rigosertib

Unknown Manufacturer

Rigosertib has been used in trials studying the treatment and basic science of MDS, RAEB, Cancer, Hepatoma, and Neoplasms, among others.

Overview

Rigosertib has been used in trials studying the treatment and basic science of MDS, RAEB, Cancer, Hepatoma, and Neoplasms, among others.

Technical identifiers

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

NEW CRYSTALLINE POLYMORPHS OF RIGOSERTIB SODIUM
EP 3870298 A1Applicant: TEVA PHARMACEUTICALS INT GMBHPriority: 2018
EP
US
WO
6 publications
Deuterated rigosertib
US 9249093 B2Applicant: CONCERT PHARMACEUTICALS INCPriority: 2013
US
3 publications
USE OF RIGOSERTIB TO TREAT RNA VIRUS INFECTIONS
EP 4157248 A4Applicant: ICAHN SCHOOL MED MOUNT SINAIPriority: 2020
EP
US
2 publications
Double-target conjugate synthesized based on PARP1 inhibitor and Rigosertib as well as preparation method and application of double-target conjugate
CN 119462518 AApplicant: HUAIYIN INST TECHNOLOGYPriority: 2024
CN